Effectiveness of traditional non-carbapenem β-lactams vs. novel β-lactams for the treatment of carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study
BMC Infect Dis. 2024 Dec 22;24(1):1455. doi: 10.1186/s12879-024-10365-5. ABSTRACT BACKGROUND: The World Health Organization (WHO) has identified carbapenem-resistant Pseudomonas aeruginosa (CRPA) as one of the …